Press Release

  View printer-friendly version

« Back

West Pharmaceutical Services, Inc. Announces Death of J. Roffe Wike, II, Director

LIONVILLE, Pa., Sep 13, 2001 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that J. Roffe Wike, II died at home on September 10th, 2001 following a brief illness. Mr. Wike was a member of the Company's Board of Directors for almost 40 years and the son of one of the founders of the Company.

William G. Little, Chairman and Chief Executive Officer, commented, "I am deeply saddened to report the death of Mr. Wike, whose efforts and astute counsel played a major role in creating our global enterprise. His loss will be mourned by the entire extended family of West employees."

West Pharmaceutical Services, Inc. (NYSE: WST) supports global pharmaceutical and healthcare markets with products and services that enhance the effectiveness of drug delivery and product dispensing. West Pharmaceutical Services' technologies include drug formulation research and development, clinical research and laboratory services and the design, development and manufacture of components and systems for delivering pharmaceutical, healthcare and consumer products. For more information, visit West Pharmaceutical Services at and

SOURCE West Pharmaceutical Services, Inc.

CONTACT:          Michael A. Anderson, Vice President and Treasurer of West
                  Pharmaceutical Services, Inc., +1-610-594-3345; or Investors - Theresa Vogt of
                  Morgen-Walke Associates, +1-212-850-5631,; or Shoba
                  Vaitheeswaran of Schwartz Communications, +1-781-684-0770,
        , both for West Pharmaceutical Services, Inc.